AXIL Announces Next Generation of Over-the-Ear Hearing Protection and Enhancement Products
New MX Series is the next evolution in advanced earmuffs for ultimate comfort, functionality, and performance
AXIL MX PRO
LOS ANGELES, Jan. 29, 2025 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. ('AXIL' or the 'Company')(NYSE American: AXIL), a leader in innovative hearing protection, hearing enhancement, and Bluetooth®/wireless technology, announces the launch of its MX Series Earmuff line. Designed to meet the diverse needs of outdoor enthusiasts, professionals, and hobbyists, the new line introduces three state-of-the-art models:
MX Passive: Delivers top-tier passive noise reduction for best-in-class hearing protection
MX Electronic: Combines electronic hearing enhancement with automatic noise protection for a seamless experience
MX PRO: The pinnacle of innovation, featuring electronic hearing amplification, Bluetooth® wireless audio, automatic noise protection, and a 3.5mm audio jack for two-way communication
Each model comes with interchangeable plates on the outer cups, enabling users to easily switch between colors and designs for functional or aesthetic purposes. Whether a user chooses safety orange, tactical camouflage, the American flag pattern, black camo, or even apocalypse zombie designs, just to name some design choices, the MX Earmuff line offers endless customization. This feature also allows retailers to stock fewer products while providing a wide variety of color options, streamlining inventory management and enhancing the customer experience.
Additional features of the MX Series Earmuffs:
Innovative Design: The compact and modern design delivers the most comfortable approach to wearing earmuffs while maintaining bold brand appeal.
Superior Comfort: The light-weight design streamlines the effectiveness and comfort for all-day use across a wide range of activities. MX Earmuffs come with multiple pad selections to customize your comfort.
Exceptional Performance: The premium materials used in the construction of the MX Series Earmuffs, along with their rugged, yet refined, construction, ensures high performance in the most demanding environments.
Interchangeable Plates: MX Plates offer the ultimate solution for customizable options for functional and aesthetic purposes.
Eco-Friendly Packaging: The product is packaged in recyclable materials, reflecting the dedication of AXIL Brands, Inc. to environmental responsibility and sustainability.
'The MX series sets a new standard for hearing protection and enhancement with improved circuitry that delivers superior sound clarity, reliable noise reduction, and seamless Bluetooth audio integration. This all comes in the most compact form factor available on the market,' commented Tyler Smith, AXIL's National Director of Sales.
The MX Series Earmuffs are expected to be available for purchase on AXIL's website, www.goaxil.com, starting on February 15, 2025 and at select global retailers starting on March 15, 2025.
About AXIL Brands
AXIL Brands (NYSE American: AXIL) is an emerging global consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium hair and skincare products under its in-house Reviv3® brand - selling products in the United States, Canada, the European Union, and throughout Asia.
To learn more, please visit the Company's AXIL® website at www.axilbrands.com and its Reviv3® website at www.reviv3.com
Forward-Looking StatementsThis press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as 'anticipate,' 'believe,' 'expect,' 'continue,' 'will,' 'prepare,' 'should,' and 'focus,' among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management's beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management's control and may cause the Company's results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company's ability to grow its net sales and operations, including developing new products and expanding internationally, and perform in accordance with any guidance; (ii) our ability to generate sufficient revenue to support the Company's operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives; (iv) the Company's ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of the Company's customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company product costs and other costs of doing business, and reduce the Company's earnings; (vii) the Company's ability to engage in strategic partnerships and expand its distribution and retail channels; and (viii) the impact of unstable market and general economic conditions on the Company's business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company's filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Investor Relations:CORE IR (516) 222-2560investors@goaxil.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3ccc5a47-ae77-473f-94dc-87404fd0ff2c
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
White House sent letter to trading partners to push deals during tariff pause
The White House sent a letter to trading partners to push for offers by the next day while the 'reciprocal' tariffs are paused, press secretary Karoline Leavitt said on Tuesday. Leavitt, confirming reporting from Reuters, said the letter was sent from the United States trade representative 'just to give them a friendly reminder that the deadline is coming up.' Countries were given until Wednesday to provide the best trade offer to the administration. Leavitt added that Trump administration officials are still in talks with trading partners to strike deals during the 90-day pause. 'They continue to be engaged in those discussions, and this letter was simply to remind these countries that the deadline is approaching and the president expects good deals, and we are on track for that, I will emphasize,' she said. The pause was implemented on April 9, a week after President Trump's 'Liberation Day' tariffs were imposed, amid pressure from Wall Street and fellow Republicans in response to the turmoil the tariff announcement caused on the stock market. The pause will expire on July 8. The White House did not say which countries received the letter, but top officials, including Treasury Department Secretary Scott Bessent, have said they are engaged in talks with countries such as Vietnam, Japan and India. Bessent recently warned that tariffs on trading partners could go back to the rate slapped on them on 'Liberation Day' if they don't engage in good-faith negotiations. During the 90-day pause, 10 percent tariffs on trading partners other than China were put in place. The administration struck a trade deal with the United Kingdom last month, which includes billions of dollars of increased market access for American exports but was not a direct result of the country-specific tariffs. The U.S. also struck a trade agreement with China to lower the rate imposed on the country from 145 percent to 30 percent, although Trump last week said that China violated the deal. Under the agreement hashed out in April, Beijing also lowered its rate on U.S. goods from 125 percent to 10 percent. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
36 minutes ago
- Yahoo
Tom Girardi sentenced to over 7 years in prison
Disgraced former attorney Tom Girardi has been sentenced to seven years and three months in federal prison for stealing millions of dollars from injured clients in a Ponzi scheme. U.S. District Court for the Central District of California Judge Josephine L. Staton handed down the sentencing on Monday. She ordered Girardi to report to prison on July 17 and pay over $2.3 million in restitution and fines. The sentencing came on Girardi's 86th birthday. His attorney was hoping he'd remain at a medical care facility for the rest of his life, due to age-related dementia, but Judge Stanton denied that request. In 2024, a jury found the estranged husband of 'Real Housewives of Beverly Hills' star Erika Jayne guilty of defrauding clients and stealing millions of dollars from them. He was disbarred for his actions in 2022. Jayne filed for divorce from Girardi in 2020. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
42 minutes ago
- Yahoo
Perimeter Announces Closing of Prospectus Offering
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO and DALLAS, June 3, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that it has completed its previously announced prospectus offering (the "Offering") of units of the Company (the "Units") and pre-funded units of the Company. The Offering was completed on a reasonable "best efforts" agency basis pursuant to an agency agreement (the "Agency Agreement") dated May 29, 2025 between the Company and A.G.P. Canada Investments ULC (the "Agent"). Pursuant to the Offering, the Company has issued an aggregate of 10,432,801 Units at a price of $0.30 per Unit (the "Offering Price") for aggregate gross proceeds of $3,129,840. Each Unit is comprised of one common share in the capital of the Company (each a "Common Share") and one Common Share purchase warrant (each a "Warrant"). Each Warrant entitles the holder to acquire an additional Common Share for a period of 60 months, at an exercise price of $0.35. Pursuant to the terms of the Agency Agreement, the Agent was entitled to receive a cash fee equal to 7.0% of the gross proceeds raised under the Offering, and compensation options equal to 5.0% of the aggregate number of Units issued under the Offering (the "Compensation Options"), with a reduced cash commission of 3.5% and Compensation Options equal to 2.5% payable in respect of Units sold to certain purchasers on a president's list. In addition, the Agent will receive no cash commission or Compensation Options with respect to sales to certain insiders of the Company. Each Compensation Option entitles the Agent to buy one Common Share at the same price as the price per Unit under the Offering. The Compensation Options are exercisable until that date which is 36 months following the closing date. The Company intends to use the net proceeds from the Offering to continue the commercialization of its technology, establish clinical evidence and continue product development. The Company also intends to use the net proceeds for working capital and other general corporate purposes. The Company may close additional tranches of the Offering for total gross proceeds of up to $15,000,000 (inclusive of the initial closing). The Offering was completed by way of a short form prospectus dated May 29, 2025 (the "Prospectus"). The Prospectus and the Agency Agreement are available on SEDAR+ at and contain important detailed information about the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the "1933 Act") and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the 1933 Act, and applicable state securities laws. Social Capital, a control person of the Company purchased a total of 115,217 Units under the Offering. The placement to such person constituted a "related party transaction" within the meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company has relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61- 101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation in the placement as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involved the related parties, exceeded 25% of the Company's market capitalization (as determined under MI 61-101). The Company has not filed a material change report more than 21 days before the expected closing of the Offering as the details of the Offering and the participants thereof were only finalized shortly before the closing of the Offering. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The Company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the use of proceeds from the Offering and the closing of additional tranches, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. Contacts Stephen KilmerInvestor RelationsDirect: 647-872-4849Email: skilmer@ Adrian MendesChief Executive OfficerToll-free: 888-988-7465 (PINK)Email: investors@ SOURCE Perimeter Medical Imaging AI Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
